ReachMD

Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

202

LikeLikedUnlike

Episodes 1-15 of 114

Mitochondrial Matters: A Clinician’s Insights on Thymidine Kinase 2 Deficiency
NeuroFrontiers
Mitochondrial Matters: A Clinician’s Insights on Thymidine Kinase 2 Deficiency
- Bruce H. Cohen, MD, FAAN
  Peer
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
NeuroFrontiers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jay Avasarala, MD, PhD
  Peer
The Importance of the Patient Experience During the Treatment of Spinal Muscular Atrophy
Medical Industry Feature
The Importance of the Patient Experience During the Treatment of Spinal Muscular Atrophy
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Nassim Rad, MD
  Peer
- Kevin Koo, MD
  Peer
Supporting the Peripartum Period Through Perinatal Psychiatry
NeuroFrontiers
Supporting the Peripartum Period Through Perinatal Psychiatry
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Nichelle Haynes, DO
  Peer
Highlights from the 2023 Psych Congress
NeuroFrontiers
Highlights from the 2023 Psych Congress
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Craig Chepke, MD, FAPA
  Peer
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
NeuroFrontiers
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiers
Diagnosing Suspected MS: A Review of the Updated Guidelines
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Eoin Flanagan, MB, BCh
  Peer
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiers
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Psych Congress Action Center
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Clarity for Schizophrenia: The Latest in Drug Treatment
Psych Congress Action Center
Clarity for Schizophrenia: The Latest in Drug Treatment
Digital Mental Health Treatments, Part 1: The Role of Neurobehavioral Therapies in MDD
Medical Industry Feature
Digital Mental Health Treatments, Part 1: The Role of Neurobehavioral Therapies in MDD
- Mark Tacelosky, PharmD
  Peer
- Robin Nelson, MD
  Peer
- Sandeep Vaishnavi, MD, PhD
  Peer
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiers
New Drug Approved for PPD: Solving an Unmet Need
Studying the Safety of Discontinuing DMTs in MS Older Adults
NeuroFrontiers
Studying the Safety of Discontinuing DMTs in MS Older Adults
- Andrew Wilner, MD, FACP, FAAN
  Peer
- John Corboy, MD, MA
  Peer
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiers
Uncovering Disease Progression in Multiple Sclerosis
- Sergio Baranzini, PhD
  Peer
Spinal Muscular Atrophy (SMA) in Adults: Perspectives on a Treatment Choice and the Importance of Monitoring Motor Function
Medical Industry Feature
Spinal Muscular Atrophy (SMA) in Adults: Perspectives on a Treatment Choice and the Importance of Monitoring Motor Function
- Laurey Brown, PT, DPT, PCS
  Peer
- Vamshi K. Rao, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended